Analysis of the Influence of Hormone Replacement Therapy on Osteocalcin Gene Expression in Postmenopausal Women

Table 2

Ratio of Osteocalcin to control GAPDH gene relative expression in epithelial lining of the cheek and peripheral blood lymphocytes.

Research group	Sample number	Ratios of Osteocalcin to control GAPDH gene expression level in the epithelial lining of the cheek; (M ± SD)	Control group	Sample number	Ratios of Osteocalcin to control GAPDH gene expression level in the epithelial lining of the cheek; (M ± SD)	Statistically significant differences between results in control and research group; ( < 0.05)
M + HRT	15	0,03 ± 0,02	M	15	0,11 ± 0,17	No
OV + HRT	15	0,05 ± 0,05	OV	15	0,35 ± 0,21	Yes
		Ratios of Osteocalcin to control GAPDH gene expression level in peripheral blood lymphocytes; (M ± SD)			Ratios of Osteocalcin to control GAPDH gene expression level in peripheral blood lymphocytes; (M ± SD)
M + HRT	15	1,57 ± 1,22	M	15	2,02 ± 2,08	No
OV + HRT	15	2,3 ± 1,72	OV	15	0,67 ± 0,51	Yes